A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution
Clinical trial NCT00680108 · COMPLETED
Trial details
- NCT number
- NCT00680108
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-09-01
- Primary completion
- 2000-05-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.